Aclarion Inc
Veridion Score
Composite trend over time
Why is ACON moving today?
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ACON.
ACON insider activity
Aclarion Inc
4 insiders bought in the last 90 days
Net buying: $51K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | 2026-05-12 | Breidbart Scott | Insider | buy | $3.18 | 5,664 | 5,664 | $18K | SEC Form 4 |
| 2026-05-12 | 2026-05-11 | Neal David K | Insider | buy | $3.10 | 2,500 | 2,502 | $8K | SEC Form 4 |
| 2026-05-11 | 2026-05-11 | Ness Brent | Insider | buy | $3.18 | 6,289 | 6,300 | $20K | SEC Form 4 |
| 2026-05-08 | 2026-05-06 | Wesemann William | Insider | buy | $3.30 | 1,562 | 1,563 | $5K | SEC Form 4 |
| 2025-12-01 | 2025-11-26 | Ness Brent | Insider | buy | $6.20 | 10 | 11 | $62 | SEC Form 4 |
ACON contract awards, year to date.
Public federal awards linked to this ticker.
ACON lobbying filings, year to date.
Registered lobbying filings matched to Aclarion Inc.